ViewRay Akcija

ViewRay EV/OCF

Vrijednost EV/OCF (Vrednost preduzeća na operativni tok novca) od ViewRay (VRAYQ) na dan 15. авг 2026. je 0,63. Prethodne godine, EV/OCF (Vrednost preduzeća na operativni tok novca) je bio 2,59 — promjena od -75,76% (niži).

EV/OCF

0,63

YoY

-75,76%

Zadnja ažuriranja:

EV/OCF (Vrednost preduzeća na operativni tok novca) od ViewRay je 2026 0,63 . EV/OCF (Vrednost preduzeća na operativni tok novca) od ViewRay je bio 2025 2,59 . Pad je time -75,76% niži u odnosu na prethodnu godinu.
Access this data via the Eulerpool API

ViewRay Анализа акција

Šta radi ViewRay? ViewRay Inc. is an American medical technology company based in Cleveland, Ohio. It was founded in 2004 by Ivor Jankovic and specializes in the manufacturing of radiation therapy devices. The history of ViewRay begins with the idea of developing innovative technology to treat cancer patients more effectively and gently. In 2005, the company entered into an agreement with the Cleveland Clinic Lerner Research Institute to conduct research on a novel magnetic resonance-guided radiation therapy machine. The research project was led by James F. Dempsey, Chair of the Department of Radiation Oncology at the Cleveland Clinic. In 2009, the first magnetic resonance-guided radiation therapy system was delivered and implemented at the Cleveland Clinic. ViewRay's business model is based on the development and manufacturing of innovative medical devices aimed at making the treatment of cancer patients more effective and gentle. The company focuses on combining magnetic resonance imaging (MRI) and radiation therapy to ensure more precise and safer treatment. ViewRay offers various products, including the MRIdian-Linac system, an advanced radiation therapy device that utilizes MRI technology to provide real-time images of the tumor during radiation. This allows for precise targeting of the tumor while sparing the surrounding tissue. The system also offers the ability to sync radiation therapy with the patient's breathing cycle, further improving the accuracy and effectiveness of the treatment. In addition to the MRIdian-Linac system, ViewRay also offers the MRIdian-MRI system, which is solely dedicated to imaging. The MRIdian-MRI is a diagnostic instrument that allows for better visualization of tissue and tumor studies. The system uses the same MRI technology as the MRIdian-Linac to generate radiation-free images. ViewRay has also specialized in the development of software tools that assist doctors in better planning and monitoring radiation therapy. This includes the RayCare Oncology Information System, which provides a comprehensive workflow and management platform, as well as the RayStation Treatment Planning Software, which enables more precise radiation therapy planning. In terms of market reach, ViewRay has a global presence. The company has a strong presence in North America, Europe, and Asia, and works closely with leading research institutes and hospitals to evaluate and improve the effectiveness and efficiency of its technologies. Overall, ViewRay has developed an innovative and unique portfolio of products and solutions that improve radiation therapy and increase accuracy and safety for patients and doctors. The company is a leader in the development of MRI-guided radiation therapy systems and is expected to continue playing a significant role in the medical technology industry in the future. ViewRay je jedna od najpopularnijih kompanija na Eulerpool.

Često postavljena pitanja o akciji ViewRay

EV/OCF (Vrednost preduzeća na operativni tok novca) kompanije ViewRay iznosi 0,63 u 2026. godini.

EV/OCF (Vrednost preduzeća na operativni tok novca) od ViewRay se promijenio sa 2,59 na 0,63, što predstavlja promjenu od -75,76%. Vrijednost je niži nego prethodne godine.

Na Eulerpool-u možete pronaći potpuni historijski razvoj EV/OCF (Vrednost preduzeća na operativni tok novca) ViewRay od 2006. — sa godišnjim vrijednostima, grafikonima i detaljnom analizom.

EV/OCF poredi vrednost preduzeća sa operativnim tokom novca, mereći koliko investitori plaćaju po jedinici gotovine generisane iz poslovanja.

Da biste proverili EV/OCF (Vrednost preduzeća na operativni tok novca)'s, bitno je da ga uporedite sa konkurentima u istoj industriji i sektoru. Na Eulopoolu, možete pronaći direktna upoređivanja industrije za EV/OCF (Vrednost preduzeća na operativni tok novca).

Dobar varira u zavisnosti od industrije i faze razvoja preduzeća. Na Eulopoolu, možete porediti EV/OCF (Vrednost preduzeća na operativni tok novca)'s ViewRay sa sličnim preduzećima u sektoru i prosekom industrije da biste proverili da li je atraktivan.

Access this data via the Eulerpool API

Вредновање — ViewRay

Sve ključne metrike — ViewRay

Раст